Global Endowment Management, LP
EndowmentPosition in SYRE — Spyre Therapeutics, Inc.
CIK 1512237
CHARLOTTE, NC
Position in SYRE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,076,279
+$159,079 QoQ
Shares Held
12,123
-33.3% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#158
of 265 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SYRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Global Endowment Management, LP holds $1,076,279 across 1 Biotechnology name. SYRE ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYRE |
Spyre Therapeutics, Inc.
This page
|
12,123 | $1,076,279 |
All Filings in SYRE
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,076,279 | 12,123 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $917,200 | 18,184 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $595,707 | 18,184 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $304,763 | 18,184 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $272,214 | 18,184 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $293,398 | 18,184 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $423,323 | 18,184 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $534,791 | 18,184 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $427,505 | 18,184 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $689,719 | 18,184 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $11,049,142 | 513,436 | Shares | Sole | 2024-02-12 | |
| No filing history on record for this holder in this stock. | ||||||